Oncimmune
Operates as a cancer detection company. The Company focuses on the development of autoantibody assay technologies that allow cancer detection earlier than other methods. Learn more
Launch date
Employees
Market cap
€18.8m
Enterprise valuation
€24m (Public information from Sep 2024)
Share price
£0.17665 ONC.L
Company register number 04606727
Leeds England (HQ)
Authorizing premium user...